PCVX Vaxcyte, Inc.

PCVX Vaxcyte, Inc.

Healthcare · Biotechnology

Market read

POC $55.77 · VWAP $55.63 · +14.3% vs 12m avg buyer

breakout vol: expandingchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CEO, CFO + 2 others sold $2.6M, Jul 28–Aug 5

Coverage

1 watchlist

Watchlists @biotech

PCVX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PCVX belongs to, members best 30-day change first — PCVX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings PCVX reports in 17 days Nov 3

Against street estimates

How PCVX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 -2.10-1.97+6.1%Beat
May 6 -1.77-2.30-29.6%Miss
Feb 24 -1.50-1.80-19.7%Miss
Nov 4 '25 -1.24-1.56-26.3%Miss
Aug 6 '25 -1.16-1.22-5.0%Miss
May 7 '25 -0.97-1.04-6.7%Miss
Feb 25 '25 -0.99-1.02-2.6%Miss
Nov 5 '24 -0.99-0.83+16.1%Beat

PCVX research tape

2 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.